Article

Childhood Cancer Rates Related to Geographic Location

This month’s edition of Pediatrics contains a study that correlated geographic location to children’s cancer rates after studying the cases of 36,500 children diagnosed with cancer.

Cancer is the leading disease-related cause of death among children in the United States. This month’s edition of Pediatrics contains a study that correlated geographic location to children’s cancer rates after studying the cases of 36,500 children diagnosed with cancer, with the Northeast United States having the highest incidence. The study is the first to show that there are substantial regional differences in the occurrence of childhood cancer. Additionally, researchers determined that gender, age, and ethnicity also influenced childhood cancer rates; for example, the study found that boys were more likely than girls to develop lymphoid leukemia, osteosarcomas, and non-Hodgkin’s lymphoma, and childhood cancer in general was found more frequently in whites than any other race. Children age 0-14 were also found to have a significantly lower incidence of cancer than the adolescent group (15-19 years).

The rates of cancer diagnosis for children according to geographic location were as follows:

  • Northeast: 179.12 per million
  • Midwest: 165.50 per million
  • West: 165.26 per million
  • South: 158.65 per million

Researchers hope that their findings will “be useful for prioritizing childhood cancer research and control needs in terms of these demographic and geographic variations” and will hopefully provide “unprecedented opportunities for better understanding and tracking the incidence of a variety of childhood cancers."

To read more statistics on childhood cancer in the United States, visit the National Cancer Institute’s Childhood Cancers Fact Sheet (http://www.cancer.gov/cancertopics/factsheet/Sites-Types/childhood

Related Videos
Highlighting Recent Therapies for Dermatologists, with James Del Rosso, DO
Ladan Zand, MD: Obinutuzumab Promising Option for Refractory, Primary FSGS
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital
James Del Rosso, DO: Discussing What’s New in the Medicine Chest for Dermatologists
What to Look Forward To at the Fall Clinical Dermatology Conference, with Raj Chovatiya, MD, PhD
Christine N. Kay, MD: Interim Data on ATSN-201 Shows Promise for XLRS | Image Credit: Vitreo Retinal Associates
© 2024 MJH Life Sciences

All rights reserved.